Friedrich-Christian Deuschle

Title: Friedrich-Christian Deuschle: Innovator in Anticalin Technology

Introduction

Friedrich-Christian Deuschle is a notable inventor based in Freising, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of binding proteins. His work focuses on creating high-affinity anticalins that target human CD98hc, showcasing his expertise in protein engineering.

Latest Patents

Deuschle holds a patent for "High affinity anticalins directed against human CD98hc." This invention relates to a cluster of differentiation 98 heavy chain (CD98hc)-specific binding protein. The CD98hc-specific binding protein is derived from lipocalin 2 (Lcn2) and demonstrates binding capabilities to CD98hc with a Kof of 200 nM or lower. This innovation has the potential to impact therapeutic applications significantly.

Career Highlights

Friedrich-Christian Deuschle is affiliated with the Technical University of Munich, where he engages in cutting-edge research. His academic background and ongoing projects contribute to advancements in the field of molecular biology and biochemistry. His dedication to research has led to the development of innovative solutions in protein binding.

Collaborations

Deuschle has collaborated with esteemed colleagues, including André Schiefner and Volker Morath. These partnerships enhance the research environment and foster the exchange of ideas, leading to further innovations in their respective fields.

Conclusion

Friedrich-Christian Deuschle is a prominent figure in the realm of biochemistry, with a focus on high-affinity anticalins. His contributions, particularly through his patent, reflect his commitment to advancing scientific knowledge and technology. His work continues to inspire future innovations in the field.